| Next 10 |
Motley Fool News Releases and Press Releases
Motley Fool news releases, related news releases, and press releases on the OTC, NASDAQ and NYSE markets.
-
Shares of Vaxart (NASDAQ: VXRT) rocketed 40% higher on Tuesday, furthering the biotech company's sharp ascent in recent days. On Monday, Vaxart's stock skyrocketed 52%, following bullish comments by B. Riley FBR analyst Mayank Mamtani. Mamtani began coverage of Vaxart and placed a buy rat...
-
After ending things in an ugly manner yesterday and finishing down nearly 1% , the S&P 500 (SNPINDEX: ^GSPC) closed in a flourish on July 14, gaining 42 points, or 1.34%, on the day. The S&P is still down about 1% for the year, but on a total returns basis that includes dividen...
-
After ending things in an ugly manner yesterday and finishing down nearly 1% , the S&P 500 (SNPINDEX: ^GSPC) closed in a flourish on July 14, gaining 42 points, or 1.34%, on the day. The S&P is still down about 1% for the year, but on a total returns basis that includes dividen...
-
After ending things in an ugly manner yesterday and finishing down nearly 1% , the S&P 500 (SNPINDEX: ^GSPC) closed in a flourish on July 14, gaining 42 points, or 1.34%, on the day. The S&P is still down about 1% for the year, but on a total returns basis that includes dividen...
-
After ending things in an ugly manner yesterday and finishing down nearly 1% , the S&P 500 (SNPINDEX: ^GSPC) closed in a flourish on July 14, gaining 42 points, or 1.34%, on the day. The S&P is still down about 1% for the year, but on a total returns basis that includes dividen...
-
After ending things in an ugly manner yesterday and finishing down nearly 1% , the S&P 500 (SNPINDEX: ^GSPC) closed in a flourish on July 14, gaining 42 points, or 1.34%, on the day. The S&P is still down about 1% for the year, but on a total returns basis that includes dividen...
-
After ending things in an ugly manner yesterday and finishing down nearly 1% , the S&P 500 (SNPINDEX: ^GSPC) closed in a flourish on July 14, gaining 42 points, or 1.34%, on the day. The S&P is still down about 1% for the year, but on a total returns basis that includes dividen...
-
After ending things in an ugly manner yesterday and finishing down nearly 1% , the S&P 500 (SNPINDEX: ^GSPC) closed in a flourish on July 14, gaining 42 points, or 1.34%, on the day. The S&P is still down about 1% for the year, but on a total returns basis that includes dividen...
-
After ending things in an ugly manner yesterday and finishing down nearly 1% , the S&P 500 (SNPINDEX: ^GSPC) closed in a flourish on July 14, gaining 42 points, or 1.34%, on the day. The S&P is still down about 1% for the year, but on a total returns basis that includes dividen...
-
After ending things in an ugly manner yesterday and finishing down nearly 1% , the S&P 500 (SNPINDEX: ^GSPC) closed in a flourish on July 14, gaining 42 points, or 1.34%, on the day. The S&P is still down about 1% for the year, but on a total returns basis that includes dividen...
Now Trending
Trending Stock
40.19%Change Percent:
Caladrius Biosciences Inc. Company Name:
CLBS Stock Symbol:
NASDAQ Market:
caladrius.com Website:
MENU
CLBS Stock
CLBS Quote
CLBS Short
CLBS News
CLBS Articles
Get CLBS Stock Alerts
News, Short Squeeze, Breakout and More Instantly...
RECENT CLBS NEWS
-
IMV (NASDAQ: IMV ) +162% rallies on COVID-19 vaccine progress. More news on: IMV Inc., VolitionRx Limited, INmune Bio, Inc., Stocks on the move, , Read more ...
-
BASKING RIDGE, N.J., June 02, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, diseas...
-
BASKING RIDGE, N.J., May 28, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, diseas...
x
Important Investor News Alert (OTCMKTS: NXGB)
-
DAVIE, Florida , July 9, 2020 /PRNewswire/ -- NxGen Brands Inc. (OTCPK: NXGB) has registered various products with the U.S. Food and Drug Administration (FDA) to assist with the fight against the current pandemic in this corporate update. These new products include natural and organic ...
